Navigation Links
AlloSource Named One Of Colorado's Top Bioscience Companies Of The Year
Date:11/8/2013

CENTENNIAL, Colo., Nov. 8, 2013 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, today announced that is has been named one of the top Colorado bioscience companies of the year, as judged by the Colorado BioScience Association's annual awards program. AlloSource is a repeat winner, having been named the bioscience company of the year in 2007 as well.

Now in its tenth year, the Colorado BioScience Association (CBSA) Awards honor companies that have made successful achievements over the past year, showing the promise and breadth of the bioscience industry in the state.

"Amidst a new, state-of-the-art campus, product innovations, strategic partnerships and internal process improvement initiatives, 2012 and 2013 have been landmark years for AlloSource," said Thomas Cycyota, AlloSource president and CEO.  "We are incredibly proud to be a key business in the dynamic Colorado bioscience community, and look forward to continuing the development of innovative life-saving and life-enhancing allograft tissues."

The past year and a half have been particularly noteworthy for AlloSource and its continuing contributions to the bioscience community in Colorado:

  • New headquarters: In September of last year, AlloSource celebrated the opening of its new headquarter campus in Centennial, Colorado. To best accommodate its growing workforce, AlloSource constructed a 70,000 square-foot building addition, nearly doubling the size of its headquarter campus and allowing for remote Denver-based offices to be consolidated under one roof. The construction of the new headquarters employed more than 500 local skilled workers, and injected roughly $20 million into the local economy.
  • AlloMend ADM launch: In August, AlloSource introduced a new allograft, AlloMend Acellular Dermal Matrix (ADM), which can be used in a broad range of soft tissue surgical procedures such as hernia repair and post-mastectomy reconstruction. AlloMend ADM is created by removing viable cellular elements from donated human skin, leaving a collagen elastin matrix behind. Upon transplantation, the recipient's own cells infiltrate and repopulate this scaffold to begin the revascularization process. AlloMend ADM is a new way to maximize the gift of life from tissue donors, and should bring the benefits of regenerative medicine to more patients in need.
  • Partnership to create bioengineered blood vessels: In October, AlloSource partnered with Humacyte, a regenerative medicine business from North Carolina, to create bioengineered blood vessels. The blood vessels are being developed to provide vascular access for dialysis in End-Stage Renal Disease (ESRD) patients. This exciting technology could have the potential to help reduce or avoid surgical interventions and hospitalizations for patients with the disease.
  • Onsite health and wellness clinic: Amidst a nationwide discussion about how companies and individuals can access affordable healthcare, in the last month AlloSource took the bold step of opening an onsite clinic to offer more efficient, affordable and quality healthcare for its employees and their families. Now AlloSource employees, and their dependents, have access to the clinic as part of the company's medical plan and wellness program.

The winners of the Annual CBSA Awards were announced at a dinner held on November 7, at the Marriott City Center in Denver.

About AlloSource
AlloSource is a non-profit company that offers more than 200 types of precise bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures. As the world's leader in fresh cartilage tissue used for joint repair and skin allografts to heal severe burns, AlloSource has grown into one of the largest tissue networks in the country with more than 400 employees.  It is the world's largest processor of cellular bone allografts and delivers unparalleled expertise and customer service to its growing network of surgeons, partners and the country's most reputable organ procurement organizations. As one of the leading innovators in maximizing tissue donation with the goal of offering optimal solutions for healthcare providers and their patients, AlloSource is recognized by the medical community for its ability to process and provide high quality tissue. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org or our educational website, allograftpossibilities.org.

Media Contact
Colleen Kilkenny
AlloSource
720. 382. 2756
ckilkenny@allosource.org


'/>"/>
SOURCE AlloSource
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Carnegies Greg Asner named Energy/Climate Fellow by US State Department
2. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
3. Researchers aim to assemble the tree of life for all 2 million named species
4. UMass Medical School scientist named 2012 Pew Latin-American Fellow in the Biomedical Sciences
5. Top young Latin-American scientists named Pew Biomedical Fellows
6. Kendall L. Carder named recipient of the Jerlov Award
7. Winners named in 2012 AAAS Kavli Science Journalism Award Competition
8. Michael Barnett of Boston College named Professor of the Year for Massachusetts
9. Cultural anthropologist Mark Flinn named 2013 AAAS Fellow
10. Kansas State University scientists named American Association for the Advancement of Science fellows
11. UTSA physiologist William Cooke named 2013 Lecture Series Speaker by Texas Sports Medicine Chapter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: